RCKT
Rocket Pharmaceuticals, Inc. · Healthcare · Biotechnology
Last
$3.47
+$0.04 (+1.32%) 4:00 PM ET
Prev close $3.42
Open $3.52
Day high $3.54
Day low $3.41
Volume 1,280,795
Avg vol 1,978,868
Mkt cap
$379.86M
P/E ratio
-1.54
EPS
-2.25
Sector
Healthcare
AI report sections
RCKT
Rocket Pharmaceuticals, Inc.
Rocket Pharmaceuticals shows short- to medium-term price stabilization with positive 1–6 month returns and multiple bullish technical signals after a steep 12‑month drawdown. At the same time, the company remains deeply loss-making with substantial negative free cash flow and relies on external financing to support its gene therapy pipeline. Elevated short interest and a cluster of negative legal and clinical headlines indicate ongoing perception and headline risk around the RP‑A501 program.
AI summarized at 1:10 AM ET, 2025-12-24
AI summary scores
INTRADAY: 58 SWING: 62 LONG: 33
Volume vs average
Intraday (cumulative)
−14% (Below avg)
Vol/Avg: 0.86×
RSI
55.03 (Neutral)
Neutral (30–70): momentum balanced.
MACD momentum
Intraday
+0.00 (Strong)
MACD: 0.01 Signal: 0.00
Short-Term
+0.01 (Strong)
MACD: 0.04 Signal: 0.03
Long-Term
+0.01 (Strong)
MACD: 0.04 Signal: 0.02
Intraday trend score 61.52
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal